Rituximab as Maintenance Therapy in Type 1 Autoimmune Pancreatitis: An Italian Experience

Conclusions Rituximab seems be safe and effective for maintenance therapy of type 1 AIP during the first year after completing RTX infusion. However, the probability of disease relapse is high within 1 and 3 years from the last infusion.
Source: Pancreas - Category: Gastroenterology Tags: Original Articles Source Type: research